CA3098206C - Procedes d'attenuation d'interference de cible medicamenteuse dans un dosage immunologique d'anticorps anti-medicament (ada)
- Google Patents
Procedes d'attenuation d'interference de cible medicamenteuse dans un dosage immunologique d'anticorps anti-medicament (ada)
Info
Publication number
CA3098206C
CA3098206CCA3098206ACA3098206ACA3098206CCA 3098206 CCA3098206 CCA 3098206CCA 3098206 ACA3098206 ACA 3098206ACA 3098206 ACA3098206 ACA 3098206ACA 3098206 CCA3098206 CCA 3098206C
Authority
CA
Canada
Prior art keywords
drug
target
ada
drug target
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals IncfiledCriticalRegeneron Pharmaceuticals Inc
Priority claimed from PCT/US2019/040950external-prioritypatent/WO2020014194A1/fr
Publication of CA3098206A1publicationCriticalpatent/CA3098206A1/fr
Application grantedgrantedCritical
Publication of CA3098206CpublicationCriticalpatent/CA3098206C/fr
La présente invention concerne des procédés d'atténuation d'interférence de cible médicamenteuse dans un dosage immunologique d'anticorps anti-médicament (ADA), le dosage immunologique ADA comprenant un ou plusieurs réactifs de blocage de cible dans des conditions de dosage de pH basique modérées.
CA3098206A2018-07-102019-07-09Procedes d'attenuation d'interference de cible medicamenteuse dans un dosage immunologique d'anticorps anti-medicament (ada)
ActiveCA3098206C
(fr)